126 related articles for article (PubMed ID: 2543652)
1. Labelling of monoclonal antibodies 10B, 8C, and M2A with indium-111.
Reilly R; Sheldon K; Marks A; Houle S
Int J Rad Appl Instrum A; 1989; 40(4):279-83. PubMed ID: 2543652
[TBL] [Abstract][Full Text] [Related]
2. Imaging of human ovarian tumour xenografts in nude mice using a novel 111In-labelled monoclonal antibody (10B).
Sheldon K; Reilly R; Baumal R; Marks A
Int J Rad Appl Instrum B; 1991; 18(5):519-26. PubMed ID: 1917522
[TBL] [Abstract][Full Text] [Related]
3. Automated radiolabelling of monoclonal antibodies with the Modular Lab system.
Ellison D; Kaufman J; Mather SJ
Nucl Med Commun; 2010 Feb; 31(2):173-7. PubMed ID: 19952855
[TBL] [Abstract][Full Text] [Related]
4. Effect of DTPA to antibody ratio on chemical, immunological and biological properties of the 111In-labelled F(ab')2 fragment of the monoclonal antibody 431/31.
Kuhlmann L; Steinsträsser A
Int J Rad Appl Instrum B; 1988; 15(6):617-27. PubMed ID: 3251897
[TBL] [Abstract][Full Text] [Related]
5. Labeling of sarcoma associated monoclonal antibody with 111In, 67Ga and 125I.
Lavie E; Boazi M; Weininger J; Bitton M; Yosilevski G; Front D; Hirshaut Y; Robinson E; Bartal AH
Radiother Oncol; 1987 Feb; 8(2):129-35. PubMed ID: 3562892
[TBL] [Abstract][Full Text] [Related]
6. In vitro stability of EDTA and DTPA immunoconjugates of monoclonal antibody 2G3 labeled with indium-111.
Reilly R; Lee N; Houle S; Law J; Marks A
Int J Rad Appl Instrum A; 1992 Aug; 43(8):961-7. PubMed ID: 1330982
[TBL] [Abstract][Full Text] [Related]
7. The preparation and characterisation of 111In-labelled 791T/36 monoclonal antibody for tumour immunoscintigraphy.
Perkins AC; Pimm MV; Birch MK
Eur J Nucl Med; 1985; 10(7-8):296-301. PubMed ID: 3859410
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the cyclic anhydride and mixed anhydride methods for 111In-DTPA chelation to monoclonal antibodies.
Wang TS; Srivastava SC; Fawwaz RA; Giacomini P; Ferrone S; Richards P; Hardy M; Alderson PO
Nuklearmedizin; 1984 Aug; 23(4):193-5. PubMed ID: 6483630
[TBL] [Abstract][Full Text] [Related]
9. Preparation and immunoreactivity of high specific activity indium-111-DTPA labeled monoclonal antibody (MoAb) using ultrapure indium-111.
Zoghbi SS; Neumann RD; Gottschalk A
Invest Radiol; 1986 Oct; 21(10):788-92. PubMed ID: 3771149
[TBL] [Abstract][Full Text] [Related]
10. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
Jakowatz JG; Beatty BG; Vlahos WG; Porudominsky D; Philben VJ; Williams LE; Paxton RJ; Shively JE; Beatty JD
Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043
[TBL] [Abstract][Full Text] [Related]
11. Radiolabelled stripped mucin, SM3, monoclonal antibody for immunoscintigraphy of ovarian tumours.
Granowska M; Mather SJ; Jobling T; Naeem M; Burchell J; Taylor-Papadimitriou J; Shepherd J; Britton KE
Int J Biol Markers; 1990; 5(2):89-96. PubMed ID: 2283483
[TBL] [Abstract][Full Text] [Related]
12. Uptake of indium-111 in the liver of mice following administration of indium-111-DTPA-labeled monoclonal antibodies: influence of labeling parameters, physiologic parameters, and antibody dose.
Schuhmacher J; Klivényi G; Matys R; Kirchgebner H; Hauser H; Maier-Borst W; Matzku S
J Nucl Med; 1990 Jun; 31(6):1084-93. PubMed ID: 2348237
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to an epithelial ovarian adenocarcinoma: distinctive reactivity with xenografts of the original tumor and a cultured cell line.
Baumal R; Law J; Buick RN; Kahn H; Yeger H; Sheldon K; Colgan T; Marks A
Cancer Res; 1986 Aug; 46(8):3994-4000. PubMed ID: 3731068
[TBL] [Abstract][Full Text] [Related]
14. Improved synthesis and characterisation of a hydrazide derivative of diethylenetriaminepentaacetic acid for site-specific labelling of monoclonal antibodies with 111In.
Jolley C; Burnet FR; Blower PJ
Appl Radiat Isot; 1996 Jul; 47(7):623-6. PubMed ID: 8759156
[TBL] [Abstract][Full Text] [Related]
15. A kit formulated under good manufacturing practices for labeling human epidermal growth factor with 111In for radiotherapeutic applications.
Reilly RM; Scollard DA; Wang J; Mondal H; Chen P; Henderson LA; Bowen BM; Vallis KA
J Nucl Med; 2004 Apr; 45(4):701-8. PubMed ID: 15073268
[TBL] [Abstract][Full Text] [Related]
16. Targeting of lymphocytes with 111In-labelled monoclonal antibodies.
Loutfi I; Batchelor JR; Chisholm PM; Epenetos AA; Lavender JP
Nucl Med Commun; 1988 Oct; 9(10):787-96. PubMed ID: 3211438
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of a monoclonal antibody-indium-111-porphyrin conjugate.
Bedel-Cloutour CH; Maneta-Peyret L; Pereyre M; Bezian JH
J Immunol Methods; 1991 Nov; 144(1):35-41. PubMed ID: 1960404
[TBL] [Abstract][Full Text] [Related]
18. Labelling monoclonal antibodies with yttrium-90.
Mather SJ; Tolley DM; White GW
Eur J Nucl Med; 1989; 15(6):307-12. PubMed ID: 2767080
[TBL] [Abstract][Full Text] [Related]
19. Labeling anti-HER2/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent.
Blend MJ; Stastny JJ; Swanson SM; Brechbiel MW
Cancer Biother Radiopharm; 2003 Jun; 18(3):355-63. PubMed ID: 12954122
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three different methods for radiolabelling human activated T lymphocytes.
Botti C; Negri DR; Seregni E; Ramakrishna V; Arienti F; Maffioli L; Lombardo C; Bogni A; Pascali C; Crippa F; Massaron S; Remonti F; Nerini-Molteni S; Canevari S; Bombardieri E
Eur J Nucl Med; 1997 May; 24(5):497-504. PubMed ID: 9142729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
